doi: 10.1007/s11010-021-04260-9 62
Diabetes Obes Metab 19:16691680 Tonneijck L, Smits MM, Muskiet MHA, Hoekstra T, Kramer MHH, Danser AHJ et al (2016) Renal effects of DPP-4 inhibitor sitagliptin or GLP-1 receptor agonist liraglutide in overweight patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled trial
Characterising increased bone mineral density, enhanced osteocalcin production, and improved skeletal parameters , without the cortisol co-elevation-associated catabolic bone effects that confound non-selective GH secretagogue bone biology studies
218,220 5 Hack Your Habits & Lifestyle for Better Sleep A growing body of research shows several key lifestyle factors are associated with better sleep quantity and quality